Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-02
2000-02-29
Guzo, David
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
435455, 4353201, 435325, 435362, 435375, A61K 9127
Patent
active
060306386
ABSTRACT:
A novel plasmid has inserted therein the cDNA for prostaglandin synthase. The present invention further provides a method of increasing prostanoid production in vivo including the general steps of delivering a prostaglandin synthase gene to cells in vivo and hyperexpressing the gene to enhance prostanoid production in the cells.
REFERENCES:
Bone "The Pathogenesis of Sepsis" Ann. Int. Med. 115(6) 457-469, Sep. 1991.
Orkin et al. Report & Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy Dec. 7, 1995.
Hla et al. (1986), Prostaglandins vol. 32 No. 6, pp. 829-845.
DeWitt et al. (1988), Proc. Natl. Acad. Sci. USA 85: 1412-1416.
Andersson et al. (1989), J. Biol. Chem. 264(14): 8222-8229.
Felgner et al. (1987), Proc. Natl. Acad. Sci. USA 84: 7413-7417.
C. M. Gorman et al., Virology, 171:371-385 (1989).
A. F. Russo et al., Neuron, 1:311-320 (1988).
G. Ciliberto et al., Cell, 41:531-540 (1985).
R. M. Abra et al., Journal of Pharmaceutical Sciences, 72(2):203-206 (1984) .
Brigham Kenneth
Canonico Angelo
Conary Jon T.
Meyrick Barbara
Guzo David
Shuman Jon D
Vanderbilt University
LandOfFree
Plasmid for in vivo expression of prostaglandin synthase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasmid for in vivo expression of prostaglandin synthase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmid for in vivo expression of prostaglandin synthase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-680356